Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 24, 2026Portal hypertension & cirrhosisOpen Access

Correction to “Chinese Expert Consensus on the Use of Ultrasound‐Derived Fat Fraction in the Assessment of Metabolic Dysfunction‐Associated Steatotic Liver Disease (2025 Edition)”

View Full Paper
Ask AI
Bookmark
Share

Key result

A correction was issued to update the ethics statement for the Chinese Expert Consensus on ultrasound-derived fat fraction in metabolic dysfunction-associated steatotic liver disease.

Discussion

Loading...

Member takes

Overview

May inform ultrasound steatosis assessment in MASLD; leaves open prospective validation before routine adoption.

Key Points

  • To clarify the ethical statements regarding the expert consensus on ultrasound-derived fat fraction in liver disease.
  • Reviewed and corrected the ethics statement section of the consensus document.
  • Ensured compliance with the Declaration of Helsinki.
  • Confirmed approval from the Ethics Committee of Huashan Hospital.
  • Corrected wording about the ethics statement to reflect translation and approval details.
  • Acknowledged the oversight in the ethics reporting for the consensus document.

PICO

P
Population
Metabolic Dysfunction-Associated Steatotic Liver Disease
I
Intervention / Comparator
Ultrasound-Derived Fat Fraction

Cite This Study

A 2026 study studied Metabolic Dysfunction-Associated Steatotic Liver Disease. Ultrasound-Derived Fat Fraction was evaluated. A correction was issued to update the ethics statement for the Chinese Expert Consensus on ultrasound-derived fat fraction in metabolic dysfunction-associated steatotic liver disease.

synapsesocial.com/papers/6a3c239bd15afadd906fa52dhttps://doi.org/10.1002/poh2.70054
View Full Paper
Ask AI
Bookmark
Share